This page shows the latest Prescription Digital Therapeutics news and features for those working in and with pharma, biotech and healthcare.
MedRhythms is in the process of developing next-generation prescription digital therapeutics, covering a range of indications in neurology. ... He added: “Pioneering in digital therapeutics exemplifies Biogen’s commitment to advance novel therapies
Pear Therapeutics is a pioneer of so-called digital therapeutics, having gained the first ever such approval from the FDA in 2017, for its treatment for patients with Substance Use Disorder ... Its Prescription Digital Therapeutics (PDTs) are app-based
validated software-based therapeutics, known as Prescription Digital Therapeutics (PDT). ... Richard Francis, CEO, Sandoz. "New digital therapeutics such as reSET-O also have the potential to fundamentally change how patients interact with their
Novartis shares our vision for prescription digital therapeutics that work alongside drugs to deliver superior patient outcomes. ... We believe this collaboration further supports the clinical viability of prescription digital therapeutics as an emerging
Corey McCann, Pear’s president and CEO, said: “This is a defining moment for digital therapeutics and for patients with substance use disorder. ... We believe that prescription digital therapeutics hold promise in improving patient outcomes across a
More from news
Approximately 1 fully matching, plus 4 partially matching documents found.
See how Limbix is paving the way for prescription digital therapeutics and learn from their trials, tribulations, successes, and vision for the future. ... Address:. Impetus Digital. WaterPark Place. 20 Bay Street, 11th Floor. Toronto.
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
No results were found
Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...